Compass Therapeutics Inc

CMPX | $1.48 -0.67% -0.68% 230K

(0.0% 1d) (-34.4% 1m) (-49.5% 1y) (0.0% 2d) (0.0% 3d) (-4.2% 7d) (-67.58% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 203,631,973

Sec Filling | Patents | 26 employees

compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. novel scientific insights are validated and explored deeply inside our labs before compass pursues the best proprietary combinations of therapeutics into human clinical trials. in 2015, compass quietly closed a $120mm series a financing to fund our ambitious plan to build a fully-integrated biopharmaceutical company from the ground up. our investors are among the most sophisticated venture capitalists in the industry who exemplify our philosophy of building long term economic value only by delivering therapeutics with meaningful efficacy beyond

add to watch list Paper trade email alert is off

Press-releases

Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -4.23% | O: 2.93% H: 3.8% C: -0.63%
ctx-8371 first tumors therapeutics study

Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -11.98% | O: -4.19% H: 9.38% C: 1.25%
conference therapeutics foundation

Compass Therapeutics to Participate in the Stifel Targeted Oncology Days
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -15.27% | O: -8.93% H: 12.03% C: 1.27%
therapeutics

Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-09 (Crawled : 16:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -13.53% | O: 2.06% H: 0.0% C: 0.0%
association tumors cancer research for meeting therapeutics negative

Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
Published: 2024-03-21 (Crawled : 13:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -30.66% | O: 2.83% H: 3.21% C: 2.75%
update therapeutics financial results

Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -15.52% | O: 5.17% H: 1.09% C: -2.73%
conference biopharma global therapeutics

Compass Therapeutics Provides Corporate Update
Published: 2024-01-05 (Crawled : 13:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -5.16% | O: 0.0% H: 10.0% C: 5.16%
update therapeutics

Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-09 (Crawled : 12:30) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -14.53% | O: 2.33% H: 0.57% C: -8.52%
update therapeutics financial results

Compass Therapeutics to Participate in Upcoming Investor Events
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -16.48% | O: 0.0% H: 1.14% C: 0.0%
therapeutics

Compass Therapeutics to Participate in Upcoming Investor Events
Published: 2023-08-30 (Crawled : 12:00) - globenewswire.com
CMPX | $1.48 -0.67% -0.68% 230K

Professional, Scientific, and T...

| -39.75% | O: -3.28% H: 9.01% C: 2.97%
therapeutics

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001171843-24-001275	4	2024-03-11	2024-03-08	Buy	A	40000	40000
0001171843-24-000715	4	2024-02-09	2024-02-08	Sell	F	49198	3124426
0001171843-24-000714	4	2024-02-09	2024-02-08	Sell	F	44782	6570566